Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | REGN | VRTX | GILD | ||
Company | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 970.38 | 419.48 | 73.25 | ||
High | 970.79 | 420.67 | 73.87 | ||
Low | 959.25 | 415.06 | 73.20 | ||
Last | 962.49 | 418.01 | 73.25 | ||
Change | -3.81 | +0.69 | +0.24 | ||
% Change | -0.39% | +0.17% | +0.33% | ||
Volume | 461,800 | 1,092,100 | 8,369,700 | ||
20-Day Average Volume | 426,175 | 1,007,235 | 7,467,220 | ||
Previous Close | 966.30 | 417.32 | 73.01 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 966.83 | 415.23 | 73.54 | ||
20-Day Raw Stochastic | 37.10% | 40.86% | 30.35% | ||
20-Day Relative Strength | 52.64% | 50.80% | 44.95% | ||
Weighted Alpha | +22.60 | +31.10 | -12.10 | ||
Today's Opinion | 80% Buy | 56% Buy | 88% Sell | ||
Previous Opinion | 80% Buy | 56% Buy | 88% Sell | ||
Last Month's Opinion | 100% Buy | 100% Buy | 40% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -0.57% since 03/21/24 | +0.55% since 03/21/24 | +0.22% since 03/21/24 | ||
Low | 952.47 on 03/25/24 | 412.19 on 03/22/24 | 72.11 on 03/26/24 | ||
High | 977.39 on 03/22/24 | 420.67 on 03/28/24 | 73.87 on 03/28/24 | ||
1-Month | |||||
%Chg | -2.54% since 02/28/24 | -2.10% since 02/28/24 | +0.76% since 02/28/24 | ||
Low | 947.37 on 03/20/24 | 406.97 on 03/15/24 | 71.92 on 02/29/24 | ||
High | 990.30 on 02/29/24 | 433.99 on 03/04/24 | 76.21 on 03/11/24 | ||
3-Month | |||||
%Chg | +9.16% since 12/28/23 | +2.14% since 12/28/23 | -9.72% since 12/28/23 | ||
Low | 871.39 on 01/02/24 | 403.43 on 01/02/24 | 71.37 on 02/16/24 | ||
High | 998.33 on 02/28/24 | 448.40 on 01/30/24 | 87.86 on 01/19/24 | ||
6-Month | |||||
%Chg | +15.33% since 09/28/23 | +18.58% since 09/28/23 | -2.88% since 09/28/23 | ||
Low | 769.19 on 10/27/23 | 341.85 on 10/03/23 | 71.37 on 02/16/24 | ||
High | 998.33 on 02/28/24 | 448.40 on 01/30/24 | 87.86 on 01/19/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 106,063,024 | 107,797,104 | 90,903,080 | ||
Shares Outstanding, K | 109,762 | 258,308 | 1,245,077 | ||
Annual Sales | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 | ||
Annual Net Income | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 | ||
Last Quarter Sales | 3,434,300,000 | 2,517,700,000 | 7,114,000,000 | ||
Last Quarter Net Income | 1,159,600,000 | 968,800,000 | 1,429,000,000 | ||
60-Month Beta | 0.11 | 0.35 | 0.18 | ||
Per-Share Information | |||||
Most Recent Earnings | 11.86 on 02/02/24 | 4.20 on 02/05/24 | 1.72 on 02/06/24 | ||
Latest Earnings Date | 05/02/24 | 05/06/24 | 04/25/24 | ||
Most Recent Dividend | N/A | N/A | 0.770 on 03/14/24 | ||
Next Ex-Dividends Date | N/A | N/A | 03/14/24 | ||
Ratios | |||||
Price/Earnings ttm | 25.64 | 31.14 | 10.78 |